Dan Troy

Président chez National Chamber Litigation Center

Profil

Daniel E.
Troy is currently the Chairman at the National Chamber Litigation Center since 2008, the Secretary & Director at Human Genome Sciences, Inc. since 2012, the Director at NeuroRx, Inc. since 2018, and a Member of The American Law Institute.
Previously, he served as the Chairman-Administrative Law Section at the American Bar Association in 2007, Chairman of the Civil Justice Reform Group, Independent Director at NRX Pharmaceuticals, Inc. from 2021 to 2022, Chief Business & Administrative Officer at Valo Health, Inc., Senior Vice President & General Counsel at GSK Plc from 2008 to 2018, Chief Counsel at the US Food & Drug Administration, and Partner at Sidley Austin LLP from 2005 to 2008.
He also has a background in law, having studied at Columbia Law School and being a member of the Law Review and a Kent Scholar.
He completed his undergraduate studies at Cornell University.

Postes actifs de Dan Troy

Sociétés	Poste	Début
Human Genome Sciences, Inc.	Directeur/Membre du Conseil	30/07/2012
National Chamber Litigation Center	Président	01/01/2008
The American Law Institute	Corporate Officer/Principal	-
NeuroRx, Inc.	Directeur/Membre du Conseil	01/01/2018

Anciens postes connus de Dan Troy

Sociétés	Poste	Fin
NRX PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	18/07/2022
GSK PLC	Conseiller Juridique Général	01/08/2018
Sidley Austin LLP	Corporate Officer/Principal	01/01/2008
American Bar Association	Corporate Officer/Principal	01/01/2007
Valo Health, Inc.	Directeur Administratif	-